Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.
Offer reference number: CM/PHR/20/5606
CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£261,970,000 estimated from lot values | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Accord-UK Ltd | 00079585 | ~£261,970,000 estimated from lot values | - |
| Almirall | 06320852 | ~£261,970,000 estimated from lot values | - |
| Amgen Ltd | 02354269 | ~£261,970,000 estimated from lot values | - |
| AstraZeneca | 03674842 | ~£261,970,000 estimated from lot values | LOBBYIST FTI Consulting LLP (6 quarters) Incisive Health Ltd (6 quarters) Teneo Strategy Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Aventis Pharma ltd t/a Sanofi | 01535640 | ~£261,970,000 estimated from lot values | DONOR£101K across 3 donations To: Pauline Latham MP, Derek Thomas, Labour Party |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£261,970,000 estimated from lot values | - |
| Chugai Pharma UK Ltd | 02814621 | ~£261,970,000 estimated from lot values | - |
| Eli Lilly & Company Ltd | 00284385 | ~£261,970,000 estimated from lot values | DONOR£9K across 1 donation To: Conservative and Unionist Party |
| Gedeon Richter UK Ltd | 04325685 | ~£261,970,000 estimated from lot values | - |
| GlaxoSmithKline UK Limited | 04310159 | ~£261,970,000 estimated from lot values | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| Ipsen | 06751069 | ~£261,970,000 estimated from lot values | LOBBYIST Burkitt Communications Ltd (2 quarters) WA Communications Ltd (1 quarter) |
| Janssen-Cilag Ltd | 01027904 | ~£261,970,000 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Merck Serono Limited | 00990823 | ~£261,970,000 estimated from lot values | MP LINK Munira Wilson— Employment and earnings |
| Merck Sharpe & Dohme (UK) Limited | - | ~£261,970,000 estimated from lot values | - |
| Merz | - | ~£261,970,000 estimated from lot values | - |
| Novo Nordisk | 01118740 | ~£261,970,000 estimated from lot values | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Organon Pharmaceuticals UK Ltd | - | ~£261,970,000 estimated from lot values | - |
| Pfizer Ltd | 00526209 | ~£261,970,000 estimated from lot values | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Hanover Communications International Limited (3 quarters) Ovid Consulting Ltd (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Pharmacosmos UK Ltd | 03104505 | ~£261,970,000 estimated from lot values | - |
| Roche Products Ltd | 00100674 | ~£261,970,000 estimated from lot values | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Sandoz Ltd | 01547204 | ~£261,970,000 estimated from lot values | - |
| Sobi (Swedish Orphan Biovitrum Ltd) | - | ~£261,970,000 estimated from lot values | - |
| Takeda UK Ltd | 03362860 | ~£261,970,000 estimated from lot values | LOBBYIST Hill & Knowlton Limited (3 quarters) MHP Communications (2 quarters) Hanover Communications International Limited (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| Teva UK Limited | 00302461 | ~£261,970,000 estimated from lot values | - |
| Thornton and Ross Ltd | 00185947 | ~£261,970,000 estimated from lot values | - |
| UCB Pharma Ltd (primary) | - | ~£261,970,000 estimated from lot values | - |
| Vifor Pharma UK Ltd | 06514784 | ~£261,970,000 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£261,970,000 estimated from lot values | - |
Government spending data: These suppliers have received £1,022,656,479 in 5,045 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust and 21 more public bodies (2010-04-28 to 2026-03-31).